Journal Home
Search for

Volume 76, Issue 2, Pages 333-336 (1 February 2010)


View previous. 4 of 51 View next.

Integrating the Healthcare Enterprise in Radiation Oncology Plug and Play—The Future of Radiation Oncology?

May Abdel-Wahab, M.D., Ph.D.Corresponding Author Informationemail address, Ramesh Rengan, M.D., Ph.D., Bruce Curran, M.S., M.E., Stuart Swerdloff, Ph.D.§, Mika Miettinen, Colin Field, M.Sc.∗∗, Sunita Ranjitkar, M.S.H.S.††, Jatinder Palta, Ph.D.§§, Prabhakar Tripuraneni, M.D.¶¶

Received 30 September 2009; accepted 1 October 2009.

Purpose

To describe the processes and benefits of the integrating healthcare enterprises in radiation oncology (IHE-RO).

Methods

The IHE-RO process includes five basic steps. The first step is to identify common interoperability issues encountered in radiation treatment planning and the delivery process. IHE-RO committees partner with vendors to develop solutions (integration profiles) to interoperability problems. The broad application of these integration profiles across a variety of vender platforms is tested annually at the Connectathon event. Demonstration of the seamless integration and transfer of patient data to the potential users are then presented by vendors at the public demonstration event. Users can then integrate these profiles into requests for proposals and vendor contracts by institutions.

Results

Incorporation of completed integration profiles into requests for proposals can be done when purchasing new equipment. Vendors can publish IHE integration statements to document the integration profiles supported by their products. As a result, users can reference integration profiles in requests for proposals, simplifying the systems acquisition process. These IHE-RO solutions are now available in many of the commercial radiation oncology-related treatment planning, delivery, and information systems. They are also implemented at cancer care sites around the world.

Conclusions

IHE-RO serves an important purpose for the radiation oncology community at large.

 Department of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, Florida

 Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania

 Department of Radiation Oncology, Rhode Island Hospital, Brown University, City, Rhode Island

§ Elekta, Sunnyvale, California

 Varian Systems, Palo Alto, California

∗∗ Cross Cancer Institute, Edmonton, Alberta, Canada

†† American Society for Therapeutic Radiology and Oncology, Fairfax, Virginia

§§ Department of Radiation Oncology, University of Florida, Gainesville, Florida

¶¶ Department of Radiation Oncology, Scripps Institute, La Jolla, California

Corresponding Author InformationReprint requests to: May Abdel-Wahab, M.D., Department of Radiation Oncology, Miller School of Medicine, University of Miami, 1475 NW 12th Ave. (D-31), Miami, Fl 33136. Tel: (305) 243-4210; Fax: (305) 243-4363

 Conflict of interest: none.

PII: S0360-3016(09)03305-7

doi:10.1016/j.ijrobp.2009.10.001


View previous. 4 of 51 View next.